Analyst Ratings for Chemed (CHE)
CHE Rating Summary
CHE Price Target Summary
- Highest: $650.00 (UBS)
- Lowest: $520.00 (Jefferies)
- Average: $571.60
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$571.60 (+11.6%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$571.60 (+11.6%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2026 | UBS | AJ Rice | New Coverage | Buy (N/A) |
650.00 (N/A) |
498.09 (512.38) |
2.87% | Details |
| 2/27/2026 | RBC Capital » Updated 7/30/2026 |
Ben Hendrix | Downgrade | Sector Perform (Outperform) |
548.00 (436.00) |
466.60 (512.38) |
9.81% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



